Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Windlas Biotech Limited (NSE: WINDLAS), ISIN INE0H5O01029 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
WINDLAS last traded at ₹977.35 (-1.71%), with a 52-week range of ₹697.40 to ₹1181.90 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 63.31%, FIIs 2.09%, DIIs 7.24%, mutual funds 3.10%.
EquiSense Score (ECS): 73/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.